By Procos S.p.A.
To get in touch with Procos S.p.A., simply fill out the form below.
Subscribe to Supplier
Procos showcases new capabilities at CPhI China
Cameri, Italy: – Established Italian contract manufacturer (CMO) Procos will use next month’s huge CPhI and P-Mec China multiple Expo to bring its expanding capabilities to the emerging Chinese/Far Eastern market.
Procos is about to roll out its new 4000 m2 working space workshop, scheduled for completion in Autumn 2015 as a central element in its overall investment and growth strategy, focusing on its principle markets in North America, Europe and Japan as well as ‘pharmarging’ markets in the Near and Far East.
Procos will exhibit on the CBC (Shanghai) Trading Co., Ltd. stand at the Shanghai National and International Exhibition Center (SNIEC) Center. Procos plays a leading part in CBC’s specialized pharma products offerings.
The Procos team in Shanghai, led by Kingo Yamashita, head of Procos’ Sales & Marketing Division, and Clara Usanna (Sales Manager), will present details of the company’s sophisticated new facilities, as well as of its generics contract manufacturing and custom synthesis capabilities.
The new Cameri facility will enable a one third expansion in manufacturing capacity, up to 450m3, as well as new technology platforms to enable more innovative and creative solutions for demanding markets like oncology.
“We now consider China as one of the key pharmarging markets. Through CBC and our partners, we are a strong player in this market with several successful collaborations under way,” said Mr. Yamashita.
“However there is almost unlimited room for further development and we are keen to meet new partners who can benefit from the strong portfolio of Procos products and manufacturing capabilities,” he added.
“At CPhI, we will have some very interesting offers from our bolstered generic APIs pipeline as well as the new synthesis capabilities we are acquiring from our new workshop,” said Kingo Yamashita.
Procos S.p.A. is an Italian Contract Research and Manufacturing Organization (CRO, CMO) that specializes in development, scale-up and production of APIs and cGMP advanced intermediates for the pharmaceutical industry.
Procos is an important member of the international CBC Group, headquartered in Japan. This network provides Procos with global reach, reinforced with subsidiary sales offices in the USA, Slovakia, Germany and India.
Over 70 years, Procos has built up a comprehensive range of technologies and capabilities to provide high quality products and services that have been widely accepted in worldwide pharmaceutical markets. It continuously develops and adds unique generic APIs and key intermediates to its product portfolio.
Procos’ two core business sectors are the development and supply of APIs and GMP advanced intermediates along with contract manufacturing services.
Procos manufactures more than 30 products, mostly under uniquely designed synthetic methods and under strict regulatory compliance management. In contract manufacturing, Procos provides related services for the pharmaceutical industry acting as a CRO/CMO for custom synthesis on exclusive base, supporting customer from early clinical stage up to full -scale commercial production. Development services include IP analysis expertise and effective patent challenge skills.
Innovation is a driving force of Procos activity. The company’s products are based on patented technologies and cost-effective processes. Procos chemistry expertise is focused on the most complex organic reactions, including organo-metallic catalysis, multi-catalytic hydrogenation, Enantioselective and hazardous chemistry.
About CPhI and P-MEC China
Ove the past 15 years, CPhI China has established itself as the leading pharma industry business and sourcing event for Eastern Asia, representing the huge growth of the Chinese market.
Staged by global B2B events organizer and publisher, UBM Live, CPhI China a three day event opening June 24 at the SNIEC Center in Shanghai. CPhI China is co-located with five other pharma industry events, P-Mec for machinery and equipment, ICSE for outsourcing solutions BioPh for biotech solution, InnoPack for Drug Packaging and Delivery Technology and LABWorld for laboratory equipment.
The events will host more than 2,800 exhibitors and is expected to attract some 30,000 visitors from over 100 countries worldwide.
CPhI China offers rich opportunities to arrange face-to-face meetings with potential international partners and collaborators, as well as gain insights on latest industry trends.
More information at: www.cphi.com/china/home
Kingo Yamashita, Sales & Marketing Director, Procos SpA
Tel: +39 0321 642211